Genome-Based Classification and Therapy of Prostate Cancer

por Angeles, Arlou Kristina, Bauer, Simone, Ratz, Leonie, Klauck, Sabine M., Sültmann, Holger
Publicado 2018

Liquid Biopsies beyond Mutation Calling: Genomic and Epigenomic Features of Cell-Free DNA in Cancer

por Angeles, Arlou Kristina, Janke, Florian, Bauer, Simone, Christopoulos, Petros, Riediger, Anja Lisa, Sültmann, Holger
Publicado 2021

Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer

por Eickelschulte, Samaneh, Riediger, Anja Lisa, Angeles, Arlou Kristina, Janke, Florian, Duensing, Stefan, Sültmann, Holger, Görtz, Magdalena
Publicado 2022

Phenotypic characterization of the novel, non-hotspot oncogenic KRAS mutants E31D and E63K

por Angeles, Arlou Kristina J., Yu, Ryan Timothy D., Cutiongco-De La Paz, Eva Maria, Garcia, Reynaldo L.
Publicado 2019

Integrated circulating tumour DNA and cytokine analysis for therapy monitoring of ALK-rearranged lung adenocarcinoma

por Angeles, Arlou Kristina, Janke, Florian, Daum, Ann-Kathrin, Reck, Martin, Schneider, Marc A., Thomas, Michael, Christopoulos, Petros, Sültmann, Holger
Publicado 2023

Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients

por Janke, Florian, Angeles, Arlou Kristina, Riediger, Anja Lisa, Bauer, Simone, Reck, Martin, Stenzinger, Albrecht, Schneider, Marc A., Muley, Thomas, Thomas, Michael, Christopoulos, Petros, Sültmann, Holger
Publicado 2022

Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis

por Angeles, Arlou Kristina, Christopoulos, Petros, Yuan, Zhao, Bauer, Simone, Janke, Florian, Ogrodnik, Simon John, Reck, Martin, Schlesner, Matthias, Meister, Michael, Schneider, Marc A., Dietz, Steffen, Stenzinger, Albrecht, Thomas, Michael, Sültmann, Holger
Publicado 2021

Non-Redundant and Overlapping Oncogenic Readouts of Non-Canonical and Novel Colorectal Cancer KRAS and NRAS Mutants

por Alcantara, Krizelle Mae M., Malapit, Joshua Reginald P., Yu, Ryan Timothy D., Garrido, Jose Antonio Ma. G., Rigor, John Paul T., Angeles, Arlou Kristina J., Cutiongco-de la Paz, Eva Maria, Garcia, Reynaldo L.
Publicado 2019

Serum cytokines predict efficacy and toxicity, but are not useful for disease monitoring in lung cancer treated with PD-(L)1 inhibitors

por Schindler, Hannah, Lusky, Fabienne, Daniello, Lea, Elshiaty, Mariam, Gaissmaier, Lena, Benesova, Karolina, Souto-Carneiro, Margarida, Angeles, Arlou Kristina, Janke, Florian, Eichhorn, Florian, Kazdal, Daniel, Schneider, Marc, Liersch, Stephan, Klemm, Sarah, Schnitzler, Paul, Stenzinger, Albrecht, Sültmann, Holger, Thomas, Michael, Christopoulos, Petros
Publicado 2022

Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA

por Dietz, Steffen, Christopoulos, Petros, Yuan, Zhao, Angeles, Arlou Kristina, Gu, Lisa, Volckmar, Anna-Lena, Ogrodnik, Simon J., Janke, Florian, Fratte, Chiara Dalle, Zemojtel, Tomasz, Schneider, Marc A., Kazdal, Daniel, Endris, Volker, Meister, Michael, Muley, Thomas, Cecchin, Erika, Reck, Martin, Schlesner, Matthias, Thomas, Michael, Stenzinger, Albrecht, Sültmann, Holger
Publicado 2020